Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion type Assertion NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_head.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion description "[Whereas individuals heterozygous for most alpha-chain mutations possess approximately 25% abnormal hemoglobin, heterozygotes for the alpha-chain variant Hb G Philadelphia synthesize either 33% or 50% Hb G. Both variable gene dosage and interaction with alpha-thalassemia have been proposed to explain this observation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_provenance.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion evidence source_evidence_literature NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_provenance.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion SIO_000772 6935689 NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_provenance.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion wasDerivedFrom befree-20140225 NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_provenance.
- NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_assertion wasGeneratedBy ECO_0000203 NP877610.RAlyHt9wKJU2HA6K-FHT269eKQtFPShbwKASQ7e493YWg130_provenance.